You are here

Study Evaluating the Nasopharyngeal Carriage in Healthy Children

Last updated on December 1, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Offenbach, , 63069 Germany
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy Subjects
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
3-4 months
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Main inclusion criteria:

- Age at enrolment 3 to 4 month Main

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Malformation or injury of the nasopharynx

- Known or suspected immunodeficiency

- Relevant immunosuppression

- Use of antibiotics up to 10 days prior to study inclusion

NCT00768833
Pfizer
Completed
Study Evaluating the Nasopharyngeal Carriage in Healthy Children

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Descriptive Information
Brief TitleStudy Evaluating the Nasopharyngeal Carriage in Healthy Children
Official TitleNasopharyngeal Carriage in Children After Introduction of General Pneumococcal Immunization in Germany
Brief SummaryThe purpose of this study is to assess the prevalence of pneumococcal stereotypes in the nasopharynx of healthy children and to describe the changes of nasopharyngeal carriage at different ages over time.
Detailed DescriptionNot Provided
Study TypeObservational
Study DesignObservational Model: Cohort
Time Perspective: Prospective
Target Follow-Up DurationNot Provided
BiospecimenNot Provided
Sampling MethodNon-Probability Sample
Study Populationcommunity sample
ConditionHealthy Subjects
InterventionNot Provided
Study Groups/CohortsNot Provided
Publications *Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment StatusCompleted
Actual Enrollment
 (submitted: August 20, 2014)
242
Original Estimated Enrollment
 (submitted: October 7, 2008)
240
Actual Study Completion DateAugust 2014
Actual Primary Completion DateAugust 2014   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

Main inclusion criteria:

  • Age at enrolment 3 to 4 month Main

Exclusion Criteria:

  • Malformation or injury of the nasopharynx
  • Known or suspected immunodeficiency
  • Relevant immunosuppression
  • Use of antibiotics up to 10 days prior to study inclusion
Sex/Gender
Sexes Eligible for Study:All
Ages3 Months to 4 Months   (Child)
Accepts Healthy VolunteersYes
ContactsContact information is only displayed when the study is recruiting subjects
Listed Location CountriesGermany
Removed Location Countries  
 
Administrative Information
NCT NumberNCT00768833
Other Study ID Numbers0887X1-4453
Has Data Monitoring CommitteeNo
U.S. FDA-regulated ProductNot Provided
IPD Sharing StatementNot Provided
Responsible PartyPfizer
Study SponsorPfizer
CollaboratorsNot Provided
Investigators
Study Director:Pfizer CT.gov Call CenterPfizer
PRS AccountPfizer
Verification DateAugust 2014

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now